Trilogy Capital’s Hartford Multifactor Developed Markets ex-US ETF RODM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Sell
74,625
-232
-0.3% -$9.49K 0.12% 140
2026
Q1
$2.95M Sell
74,857
-7,723
-9% -$302K 0.13% 127
2025
Q4
$3.05M Sell
82,580
-4,802
-5% -$174K 0.14% 126
2025
Q3
$3.1M Sell
87,382
-12,422
-12% -$433K 0.14% 106
2025
Q2
$3.4M Sell
99,804
-27,746
-22% -$903K 0.17% 87
2025
Q1
$3.95M Sell
127,550
-528,234
-81% -$15.9M 0.21% 73
2024
Q4
$18.6M Buy
655,784
+3,489
+0.5% +$103K 0.96% 30
2024
Q3
$19.9M Sell
652,295
-14,494
-2% -$422K 1% 28
2024
Q2
$18.4M Sell
666,789
-398,109
-37% -$11.2M 1% 29
2024
Q1
$29.8M Sell
1,064,898
-70,290
-6% -$1.92M 1.72% 16
2023
Q4
$31.1M Sell
1,135,188
-99,738
-8% -$2.59M 1.93% 13
2023
Q3
$31.7M Sell
1,234,926
-34,549
-3% -$910K 2.14% 14
2023
Q2
$34.3M Sell
1,269,475
-54,066
-4% -$1.45M 2.19% 12
2023
Q1
$34.8M Buy
1,323,541
+3,165
+0.2% +$82.2K 2.48% 12
2022
Q4
$32.7M Buy
1,320,376
+99,466
+8% +$2.37M 2.32% 11
2022
Q3
$26.5M Buy
1,220,910
+34,796
+3% +$852K 2.38% 10
2022
Q2
$29.5M Buy
1,186,114
+33,030
+3% +$901K 2.57% 10
2022
Q1
$33.6M Buy
1,153,084
+57,289
+5% +$1.67M 2.41% 11
2021
Q4
$33M Buy
1,095,795
+30,734
+3% +$933K 2.47% 12
2021
Q3
$32.1M Sell
1,065,061
-53,160
-5% -$1.65M 2.44% 12
2021
Q2
$34.7M Sell
1,118,221
-9,183
-0.8% -$285K 2.55% 12
2021
Q1
$33.5M Buy
1,127,404
+3,519
+0.3% +$102K 2.56% 9
2020
Q4
$31.8M Buy
1,123,885
+59,367
+6% +$1.61M 2.6% 9
2020
Q3
$27.6M Buy
1,064,518
+11,191
+1% +$289K 2.63% 9
2020
Q2
$27M Buy
1,053,327
+1,000
+0.1% +$23.7K 2.67% 10
2020
Q1
$24.3M Buy
1,052,327
+76,406
+8% +$2.04M 2.69% 11
2019
Q4
$28.7M Buy
+975,921
New +$28M 2.81% 8

Other funds holding RODM

Trilogy Capital's RODM Position: Q2 2026 in Review

Trilogy Capital reduced its Hartford Multifactor Developed Markets ex-US ETF (RODM) stake by 0.31% in Q2 2026, selling an estimated $9.49K and leaving 74,625 shares worth $3.02M. The position accounts for 0.12% of the portfolio, ranked #140.

Trilogy Capital first reported a position in RODM in Q4 2019 and has held it in 27 quarters since. The position peaked at $34.8M in Q1 2023. 16 funds tracked by Wall St. Rank hold RODM as of Q2 2026.

  • Trilogy Capital held 74,625 shares of Hartford Multifactor Developed Markets ex-US ETF worth $3.02M as of Q2 2026.
  • Trilogy Capital sold 232 Hartford Multifactor Developed Markets ex-US ETF shares in Q2 2026, an estimated $9.49K.
  • Hartford Multifactor Developed Markets ex-US ETF made up 0.12% of Trilogy Capital's portfolio in Q2 2026, its #140 holding.
  • Trilogy Capital first reported a position in Hartford Multifactor Developed Markets ex-US ETF in Q4 2019 and has held it in 27 quarters since.
  • Trilogy Capital's Hartford Multifactor Developed Markets ex-US ETF position peaked at $34.8M in Q1 2023.
  • 16 funds tracked by Wall St. Rank held Hartford Multifactor Developed Markets ex-US ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.